Comparing Two Treatments for Malaria in Nigerian Children
Author Information
Author(s): Ayede Idowu Adejumoke, Falade Adegoke Gbadegesin, Sowunmi Akintunde, Jansen Frans Herwig
Primary Institution: University College Hospital, Ibadan, Nigeria
Hypothesis
Is the efficacy of artesunate/sulphamethoxypyrazine/pyrimethamine (AS + SMP) similar to that of artesunate/amodiaquine (AS + AQ) for treating uncomplicated Plasmodium falciparum malaria in children?
Conclusion
Both AS + SMP and AS + AQ are similarly effective and safe for treating uncomplicated malaria in Nigerian children.
Supporting Evidence
- The PCR corrected cure rates for day 28 were 97.9% for AS + AQ and 95.6% for AS + SMP.
- The re-infection rate was significantly lower in the AS + AQ group compared to the AS + SMP group.
- Both treatments were well tolerated with no serious adverse events reported.
Takeaway
This study tested two malaria treatments in kids and found that both worked well and were safe.
Methodology
A randomized, controlled, open-label trial with 500 children aged 1-13 years, comparing two treatment regimens over 28 days.
Potential Biases
Possible bias due to loss to follow-up and differences in demographic characteristics between treatment groups.
Limitations
Loss to follow-up and potential biases in treatment assignment.
Participant Demographics
Children aged 1 to 13 years, with a mix of sexes and varying weights.
Statistical Information
P-Value
0.021
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website